Brief: Medical Developments International Says It Discontinued Preparation Of China Clinical Trials For Penthrox
18/01/2023 01:00
Jan 18 (Reuters) - Medical Developments International
Ltd MVP.AX :
* DISCONTINUED PREPARATION OF CLINICAL TRIALS FOR PENTHROX
IN
CHINA
* WILL RECOGNIZE NET NON-CASH INCOME OF ABOUT A$11 MILLION
(BEFORE
TAX) RELATING TO CHINA IN ITS FY23 HY RESULTS
Source text for Eikon: ID:nASX92jnVg
Further company coverage: MVP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medical Developments International
See all newsBrief: Medical Developments International Reports Group Revenue For Q1 FY27 Of A$10.2 Million
Brief: Medical Developments International Says CEO Brent MacGregor Intends To Step Down
Australia's Medical Developments International gains on higher annual revenue
Brief: Medical Developments International Logs FY Full Revenue A$42.6 Million
Medical Developments International soars on robust quarterly revenue